Latest stories on TNXP
Tonix Pharmaceuticals promotes Thomas Englese to chief commercial officer
The Fly56 · neutralgeneral
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
GlobeNewswire55 · neutralgeneral
Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer
Business Insider55 · neutralgeneral
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
Business Insider56 · neutralgeneral
Tonix Pharma Names CEO Seth Lederman Interim CMO
TipRanks50 · neutralgeneral
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
Yahoo Top56 · neutralearnings
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
Tonix Pharmaceuticals Holding Corp. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Tonix Delivers A Beat, But The Real Test Starts Now
Seeking Alpha63 · neutralearnings
Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James
The Fly61 · neutralanalyst
Tonix outlines TNX-4800 Phase II with ~3,300 participants while scaling TONMYA to ~150 reps by September
Seeking Alpha67 · bullishproduct/pr
Tonix Pharmaceuticals Holding Corp. (TNXP) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Tonix Pharmaceuticals Q2 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Tonix’s TONMYA Net Sales Surge 197% and Coverage Expands—Pipeline Progress Marks Key Quarter for TNXP
August 10, 2026
MarketChameleon67 · bullishproduct/pr
Tenax Sinks 87 To 1 69 After Hypertension Study Failure
The Fly12 · bearishearnings
Tonix Pharmaceuticals Nearly Triples TONMYA Sales While Expanding Coverage to 136 Million Lives and Advancing R&D Pipeline
August 10, 2026
MarketChameleon73 · bullishproduct/pr
Tonix Pharmaceuticals Reports Q2 Eps 2 44 Consensus 2 62
The Fly34 · bearishearnings
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral
Tonix Pharmaceuticals GAAP EPS of -$2.44 beats by $0.27, revenue of $13.5M beats by $5.78M
Seeking Alpha63 · neutralearnings
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
Business Insider56 · neutralearnings
Tonix Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
Tonix Pharmaceuticals Holding Corp. (TNXP) files 8-K
SEC 8-K50 · neutralgeneral